Symptoms Illustrated. Not an actual patient.

Seborrheic Dermatitis?

ORYVE® IT
RELIEVE IT

ZORYVE  has the power and
versatility to be your go-to topical.1
Not a steroid. No boxed warning
ZORYVE (roflumilast) topical foam 0.3%ZORYVE (roflumilast) topical foam 0.3%
Simple once-daily treatmentSimple once-daily treatment

For age 9+

Powerful skin clearance
and rapid itch relief1,2

See Efficacy Data

Safe, long-term disease
control for any skin and hair type1,3

View Safety Data

Simple, once-daily
treatment1

Discover Elegant Formulations

77% of patients achieved IGA Success at Week 8 with ZORYVE foam vs 53% with vehicle.1

In STRATUM, 63% of patients experienced WI-NRS Success at Week 8 with ZORYVE foam vs 41% with vehicle.4

ZORYVE foam has the potential to become the standard of care for seborrheic dermatitis.”

—Arcutis Chief Medical Officer Patrick Burnett, MD, PhD, FAAD

ZORYVE (roflumilast) topical foam, 0.3%
ZORYVE (roflumilast) topical foam, 0.3%
ZORYVE Direct, Patient Access Support Made Easy

Committed to affordable patient access
across all indications

The ZORYVE Direct Savings Program helps eligible, commercially insured patients get access and start ZORYVE treatment quickly and easily*†

Patient Access Support

Savings Program

Adherence Support

Learn About Patient
Access Support

*Prescriptions will be delivered to the patient 1–2 days after processing.

†Subject to eligibility criteria and maximum program limitation. This offer is not valid for patients without commercial drug insurance or whose prescription claims are eligible to be reimbursed, in whole or in part, by any government program. Please see Terms and Conditions.

Connect With Us

Request a
Representative